Sutton Wealth Advisors’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-779
| Closed | -$25.9K | – | 1665 |
|
|
2022
Q4 | $25.9K | Hold |
779
| – | – | 0.01% | 593 |
|
|
2022
Q3 | $24.6K | Hold |
779
| – | – | 0.01% | 594 |
|
|
2022
Q2 | $23.7K | Hold |
779
| – | – | 0.01% | 614 |
|
|
2022
Q1 | $20.2K | Buy |
779
+219
| +39% | +$5.21K | 0.01% | 709 |
|
|
2021
Q4 | $11.4K | Buy |
560
+49
| +10% | +$940 | ﹤0.01% | 891 |
|
|
2021
Q3 | $9.83K | Buy |
511
+5
| +1% | +$100 | ﹤0.01% | 915 |
|
|
2021
Q2 | $11.2K | Buy |
506
+16
| +3% | +$339 | ﹤0.01% | 880 |
|
|
2021
Q1 | $12.9K | Hold |
490
| – | – | 0.01% | 801 |
|
|
2020
Q4 | $9.16K | Hold |
490
| – | – | ﹤0.01% | 837 |
|
|
2020
Q3 | $8.32K | Hold |
490
| – | – | ﹤0.01% | 794 |
|
|
2020
Q2 | $11.4K | Buy |
+490
| New | +$7.1K | 0.01% | 676 |
|
|
2019
Q3 | – | Sell |
-685
| Closed | -$8.14K | – | 1230 |
|
|
2019
Q2 | $8.14K | Sell |
685
-138
| -17% | -$1.66K | ﹤0.01% | 825 |
|
|
2019
Q1 | $14.5K | Hold |
823
| – | – | 0.01% | 682 |
|
|
2018
Q4 | $14.3K | Buy |
+823
| New | +$14K | 0.01% | 639 |
|
|
2017
Q3 | – | Sell |
-1,051
| Closed | -$16.6K | – | 1116 |
|
|
2017
Q2 | $16.6K | Buy |
+1,051
| New | +$15.1K | 0.01% | 595 |
|
|
2017
Q1 | – | Sell |
-735
| Closed | -$13K | – | 1085 |
|
|
2016
Q4 | $13K | Hold |
735
| – | – | 0.01% | 622 |
|
|
2016
Q3 | $14.2K | Hold |
735
| – | – | 0.01% | 563 |
|
|
2016
Q2 | $14.3K | Hold |
735
| – | – | 0.01% | 535 |
|
|
2016
Q1 | $15.1K | Buy |
+735
| New | +$14.5K | 0.01% | 506 |
|
Other funds holding VIVO
Sutton Wealth Advisors's VIVO Position: Q1 2023 in Review
Sutton Wealth Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 779 shares — an estimated $25.9K sold.
Sutton Wealth Advisors first reported a position in VIVO in Q1 2016 and held it in 19 quarters. The position peaked at $25.9K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Sutton Wealth Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Sutton Wealth Advisors sold 779 Meridian Bioscience Inc shares in Q1 2023, an estimated $25.9K.
- Sutton Wealth Advisors first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 19 quarters.
- Sutton Wealth Advisors's Meridian Bioscience Inc position peaked at $25.9K in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.